Growth Metrics

Eli Lilly (LLY) EBIT Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,642.00
Dec 31, 2025 1,298.00
Sep 30, 2025 2,331.00
Jun 30, 2025 1,897.00
Mar 31, 2025 1,334.00
Dec 31, 2024 1,406.00
Sep 30, 2024 1,051.00
Jun 30, 2024 721.00
Mar 31, 2024 619.00
Dec 31, 2023 695.00
Sep 30, 2023 938.00
Jun 30, 2023 -180.00
Mar 31, 2023 -428.00
Dec 31, 2022 855.00
Sep 30, 2022 467.00
Jun 30, 2022 398.00
Mar 31, 2022 1,274.00
Dec 31, 2021 1,114.00
Sep 30, 2021 1,135.00
Jun 30, 2021 330.00
Mar 31, 2021 415.00
Dec 31, 2020 1,933.00
Sep 30, 2020 203.00
Jun 30, 2020 697.00
Mar 31, 2020 890.00
Dec 31, 2019 815.00
Sep 30, 2019 1,332.00
Jun 30, 2019 906.00
Mar 31, 2019 519.00
Dec 31, 2018 813.00
Sep 30, 2018 -8.00
Jun 30, 2018 212.00
Mar 31, 2018 149.00
Dec 31, 2017 -140.00
Sep 30, 2017 -55.00
Jun 30, 2017 0.00
Mar 31, 2017 -491.00
Dec 31, 2016 62.00
Sep 30, 2016 -675.00
Jun 30, 2016 -725.00
Mar 31, 2016 -1,124.00
Dec 31, 2015 -958.00
Sep 30, 2015 -756.00
Jun 30, 2015 -936.00
Mar 31, 2015 -1,154.00
Dec 31, 2014 -459.00
Sep 30, 2014 -360.00
Jun 30, 2014 -1,022.00
Mar 31, 2014 -1,626.00